Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00615628 · ClinicalTrials.gov registry record
Inheritance of Osteosarcoma & Paget's Disease Through Chromosome 18:
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Terminated
- Registry status
- 8
- Enrollment target
NCT00615628 is a clinical trial that was terminated before completion, run by State University of New York - Upstate Medical University. The registered enrollment target is 8 participants.
The verdict
NCT00615628 was terminated before completion, sponsored by State University of New York - Upstate Medical University.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
Researchers have previously demonstrated loss of heterozygosity in a region on chromosome 18q, associated with osteogenic sarcomas in bone affected by Paget's disease. The loci used in this study are specifically described by those authors as showing loss of heterozygosity in 6 of 7 affected families.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2002-04 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00615628
The ClinicalTrials.gov registry entry for NCT00615628 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00615628 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00615628 about?
NCT00615628 is a clinical study titled "Inheritance of Osteosarcoma & Paget's Disease Through Chromosome 18:". Researchers have previously demonstrated loss of heterozygosity in a region on chromosome 18q, associated with osteogenic sarcomas in bone affected by Paget's disease. The loci used in this study are specifically described by those authors as showing loss of heterozygosity in 6 of 7 affected familie...
What is the current status of trial NCT00615628?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2002-04. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00615628?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.